Analyst Ratings for Charles River Labs (CRL)
CRL Rating Summary
CRL Price Target Summary
- Highest: $357.00 (UBS)
- Lowest: $219.00 (CLSA)
- Average: $303.62
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$303.62 (+1.2%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
Rating Score: 8 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/29/2026 | UBS | Kevin Caliendo | New Coverage | Buy (N/A) |
357.00 (N/A) |
294.59 (300.15) |
1.89% | Details |
| 8/6/2026 | JPMorgan | Casey Woodring | Upgrade | Overweight (Neutral) |
310.00 (180.00) |
234.12 (300.15) |
28.2% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
